On May 29, 2020, the World Health Organization launched the COVID-19 Technologies Access Pool (C-TAP) with the aim of making pandemic-related technologies—specifically, vaccines and treatments—available to its participants. Although the initiative was positively received in many developing countries, it was not well received by pharmaceutical companies, who viewed C-TAP as a threat to the patent system and, therefore, as a threat to the companies’ future research and development. Many non-governmental organizations (NGOs) supported the initiative because it was expected to help poorer countries and income groups access a vaccine. Companies, NGOs, and national governments had to decide how to engage in the process.
看看哪些人也有訂購？